Riskpilot← Back to searchSign inGet full accessBlixt Medcare AB
ABActiveOrg 5590118807Höjdgatan 6Hospital activities · NACE 8610Est. 20151-4 employees
Revenue 2024
SEK 4,2M
-4% vs 2023
EBITDA margin
61.4%
+2065% vs 2023
Equity ratio
10.7%
Financial strength
Net profit 2024
SEK 481K
+286% vs 2023
| Revenue | SEK 4,2M | -4% |
| EBITDA | SEK 2,6M | +2065% |
| Net profit | SEK 481K | +286% |
| Total assets | SEK 5,1M | +23% |
| Equity | SEK 546K | +739% |
| Employees | — | — |
Legal name
Blixt Medcare AB
Org number
5590118807
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
24 april 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinska tjänster, handel med värdepapper och fast egendom såsom fastigheter.
Address
Höjdgatan 6
Email
blixt.medcare@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 767 | 2 208 | 2 865 | 4 330 | 4 160 |
| Staff expenses | — | — | −2 165 | −3 097 | −885 |
| EBITDA | 556 | 1 180 | 469 | 118 | 2 556 |
| Depreciation & amort. | −4 | −56 | −70 | −200 | −25 |
| EBIT | 552 | 1 124 | 399 | −82 | 2 531 |
| Net financials | −4 | 12 | −28 | −43 | −1 068 |
| Profit before tax | 548 | 886 | 951 | −125 | 863 |
| Tax | −120 | −183 | −197 | −133 | −382 |
| Net profit | 428 | 703 | 753 | −258 | 481 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 540 | 3 520 | 3 980 | 4 130 | 5 087 |
| Equity | 827 | 1 347 | 851 | 65 | 546 |
| Long-term debt | 0 | 0 | 739 | 598 | 535 |
| Short-term debt | 1 383 | 1 592 | 2 390 | 3 467 | 3 407 |
| Total debt | 1 383 | 1 592 | 3 129 | 4 065 | 3 941 |
EBITDA margin
61.4%
This company
15.8%
Market median
+289% vs market
20202024
Equity ratio
10.7%
This company
38.2%
Market median
-72% vs market
20202024
Return on equity
88.1%
This company
18.4%
Market median
+379% vs market
20202024
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20202024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
8.32×
This company
0.62×
Market median
-1242% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2024 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Blixt Medcare AB 
Blixt Medcare Personlig assistans ABBoard members of Blixt Medcare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ben Behnam Mahajerzadeh-Heidari | Audit | 0 companies |
| Sinan Nadhem Amin | Board of Directors | 0 companies |
| Damla Güven Amin | Deputy Board Member | 0 companies |